logo
Site Network

Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. Oulun yliopistollinen sairaala

+35883152011
marja.krekela@pohde.fi
Source: Site record.
http://www.oys.fi

Claim This Site

Are you the site administrator? Claim this site to update information.

Basic Information

Site Overview

Source: Human-provided.

Oulu University Hospital (Oulun yliopistollinen sairaala, or OYS) is the northernmost of Finland's five university teaching hospitals. Established in 1973 and affiliated with the Faculty of Medicine at the University of Oulu, it serves as a critical healthcare powerhouse providing specialized medical care to over 750,000 residents across a vast northern region. The facility is widely recognized across Europe for clinical excellence and robust international research.

Business Status

Source: Google. OPEN

Business Category

Source: Google. University hospital

Business Subcategory

Source: Google. University hospital
Source: Trial-derived.
34Total Trials
Source: Trial-derived.
12Recruiting Trials
Source: Trial-derived.
20Active Trials
Source: Trial-derived.
9Completed Trials
Source: Trial-derived.
45Unique Conditions
Source: Trial-derived.
62Unique Sponsors

Conditions

Source: Trial-derived. Ovarian Cancer (3)Source: Trial-derived. Type 1 Diabetes (3)Source: Trial-derived. Leukemia, Acute Lymphoblastic (2)Source: Trial-derived. Acute Lymphoblastic Leukemia (1)Source: Trial-derived. Advanced Cancer (1)Source: Trial-derived. Advanced Melanoma (1)Source: Trial-derived. Allergic Rhinitis (1)Source: Trial-derived. Asthma (1)

Sponsors

Source: Trial-derived. Oulu University Hospital (11)Source: Trial-derived. University of Oulu (10)Source: Trial-derived. Tampere University Hospital (6)Source: Trial-derived. Merck Sharp & Dohme LLC (5)Source: Trial-derived. Turku University Hospital (5)Source: Trial-derived. Amgen (3)Source: Trial-derived. Bayer (3)Source: Trial-derived. Deutsche Krebshilfe e.V., Bonn (Germany) (2)

Imaging & Diagnostics

Imaging and diagnostic capabilities inferred from trial participation

Source: AI-inferred. CT Scan
Source: AI-inferred. Electrocardiography (lead count not stated)
Source: AI-inferred. MRI
Source: AI-inferred. PET-CT
Source: AI-inferred. SPECT / nuclear medicine

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. PCR / molecular
Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. Timed pharmacokinetic sampling and processing

Research Pharmacy & Investigational Product

Investigational-product capabilities inferred from trial participation

Source: AI-inferred. Hazardous / cytotoxic drug handling

Clinical Procedures

Clinical procedures inferred from trial participation

Source: AI-inferred. Intravenous infusion administration
Source: AI-inferred. Radiopharmaceutical handling and administration

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible parking lot

Additional Capabilities

Other capabilities inferred from trial participation

Source: AI-inferred. Electronic patient-reported outcome (ePRO) daily diary system